Characterization of Cationic Liposome-Mediated Gene TransferIn Vivoby Intravenous Administration
- 1 September 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (13) , 1585-1594
- https://doi.org/10.1089/hum.1997.8.13-1585
Abstract
Physicochemical properties of the cationic liposomes, including structure of the cationic lipids, cationic lipid-to-DNA ratio, liposome particle size, and inclusion of the helper lipids, were studied for their effect on the level, site, and duration time of gene expression in vivo by intravenous administration. Using a cytomegalovirus (CMV)-driven gene expression system containing either the luciferase or green fluorescence protein gene as a reporter and two cationic lipids [N-(2,3-dioleoyloxy)propyl-N,N,N-trimethylammonium chloride (DOTMA) and 1,2-dioleoyloxy-3-trimethylammonium propane (DOTAP)], we demonstrated in vivo by a single intravenous injection of DNA/liposome complexes into mice, that cationic liposomes are capable of transfecting cells in organs such as the lung, heart, liver, spleen, and kidney. Transfection efficiency is determined mainly by the structure of the cationic lipid and the ratio of cationic lipid to DNA. Although the presence of cholesterol in DOTAP liposomes did not affect transfection activity, inclusion of dioleoylphosphatidylethanolamine (DOPE) into either DOTAP or DOTMA liposomes significantly decreases liposome transfection activity in vivo. Results from time course show that gene expression in different organs is transient, with a peak level between 4 and 24 hr, dropping to less than 1% of the peak level by day 4. Experiments with repeated injections showed that the peak level of gene expression could be regained by subsequent injection. Cationic liposomes have been studied as a potential carrier for delivering genes to cells for the purpose of gene therapy. This report summarizes our studies on the identification of the physicochemical factors that are important in determining the in vivo gene delivery efficiency of cationic liposomes by intravenous administration. The results show that some of the physicochemical parameters of cationic liposomes required for an optimal transfection in vivo are different from those for optimal in vitro transfection. The data support the notion that cationic liposomes can be an efficient carrier for in vivo gene delivery.Keywords
This publication has 13 references indexed in Scilit:
- Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administrationGene Therapy, 1997
- Detailed Analysis of Structures and Formulations of Cationic Lipids for Efficient Gene Transfer to the LungHuman Gene Therapy, 1996
- The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transferBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer: A Phase I Trial of Safety and Efficacy in the Nasal Airway. University of Alabama at Birmingham, Birmingham, AlabamaHuman Gene Therapy, 1994
- Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.Proceedings of the National Academy of Sciences, 1993
- Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- A novel cationic liposome reagent for efficient transfection of mammalian cellsBiochemical and Biophysical Research Communications, 1991
- Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphilesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1990
- Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA.Proceedings of the National Academy of Sciences, 1989
- Cationic liposome-mediated transfectionNature, 1989